Santosh Mohan Chavan
About Santosh Mohan Chavan
Data last updated:
Santosh Mohan Chavan has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Franco-Indian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Franco-Indian Pharmaceuticals Private Limited at ₹989 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Franco-Indian Pharmaceuticals Private Limited U24239MH1959PTC011347 | Director | 09 Mar 2021 | 1959 | ₹989 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Mohan Chavan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Mohan Chavan
Santosh Mohan Chavan has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Franco-Indian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Franco-Indian Pharmaceuticals Private Limited at ₹989 Cr (FY 2024).
Santosh Mohan Chavan is associated with 1 company as Director, including Franco-Indian Pharmaceuticals Private Limited (₹989 Cr).
Santosh Mohan Chavan has expertise in General Business.
Santosh Mohan Chavan has 5 years in corporate governance.
By reported revenue, the largest current company of Santosh Mohan Chavan is Franco-Indian Pharmaceuticals Private Limited, with revenue of ₹989 Cr (FY 2024).
Santosh Mohan Chavan currently holds positions at 1 company: Franco-Indian Pharmaceuticals Private Limited (₹989 Cr).